ロード中...
Beta-adrenergic receptor agonist decreases VEGF levels through altered eNOS and PKC signaling in diabetic retina
Vascular endothelial cell growth factor (VEGF) is increased in diabetic macular edema. Compound 49b, a novel β-adrenergic receptor agonist, is protective in a type 1 diabetic rat model. We questioned whether Compound 49b could decrease VEGF levels, suggesting that Compound 49b may be effective again...
保存先:
| 出版年: | Growth Factors |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4791949/ https://ncbi.nlm.nih.gov/pubmed/26115368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/08977194.2015.1054990 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|